XTL BIOPHARMACEUTICALS LTD (XTLB) Historical Stock Prices

XTL BIOPHARMACEUTICALS LTD (XTLB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.

Ticker: XTLB CIK: 1023549 Exchange: Nasdaq SIC 2834: Pharmaceutical Preparations State: L3

Independent PCAOB Auditor

Explore PCAOB Audit Intelligence →
Audit Firm Barzily&Co Certified Public Accountants
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJonathan Steinberger
Audit LocationJerusalem, Israel

Latest SEC EDGAR Filings

Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions
Form Filing Date Reporting Period Description Accession Number Actions
6-K 2026-10-14 2026-10-14 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-109415 View SEC Doc Filr Page
6-K 2026-08-05 2026-08-05 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-085693 View SEC Doc Filr Page
6-K 2026-07-21 2026-07-21 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-080006 View SEC Doc Filr Page
20-F 2026-06-30 2025-12-31 ANNUAL REPORT 0001213900-26-073831 View SEC Doc Filr Page
6-K 2026-06-30 2026-06-30 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-073813 View SEC Doc Filr Page
6-K 2026-06-29 2026-06-29 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-073158 View SEC Doc Filr Page
6-K 2026-06-23 2026-06-22 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-070771 View SEC Doc Filr Page
6-K 2026-05-22 2026-05-22 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-060565 View SEC Doc Filr Page
6-K 2026-05-15 2026-05-15 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-057942 View SEC Doc Filr Page
6-K 2026-05-07 2026-05-07 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-053067 View SEC Doc Filr Page
NT 20-F 2026-04-30 2025-12-31 NOTIFICATION OF LATE FILING 0001213900-26-050305 View SEC Doc Filr Page
6-K 2026-04-29 2026-04-29 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-048875 View SEC Doc Filr Page
3 2026-03-23 2026-03-18 3 Filing 0001213900-26-032909 View SEC Doc Filr Page
3 2026-03-23 2026-03-18 3 Filing 0001213900-26-032911 View SEC Doc Filr Page
6-K 2026-03-20 2026-03-20 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-032348 View SEC Doc Filr Page
6-K 2026-03-10 2026-03-10 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-025691 View SEC Doc Filr Page
6-K 2026-02-27 2026-02-27 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-021691 View SEC Doc Filr Page
6-K 2026-02-24 2026-02-24 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-019877 View SEC Doc Filr Page
6-K 2026-02-23 2026-02-23 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-019324 View SEC Doc Filr Page
6-K 2026-02-17 2026-02-17 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-017282 View SEC Doc Filr Page
6-K 2026-01-28 2026-01-28 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-008572 View SEC Doc Filr Page
6-K 2026-01-23 2026-01-23 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-007213 View SEC Doc Filr Page
6-K 2026-01-23 2026-01-23 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-007212 View SEC Doc Filr Page
6-K 2026-01-13 2026-01-13 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-003911 View SEC Doc Filr Page
6-K 2026-01-13 2026-01-13 REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-003672 View SEC Doc Filr Page